Robert M. Wenham

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “IgA transcytosis and antigen recognition govern ovarian cancer immunity”.

IgA transcytosis and antigen recognition govern ovarian cancer immunity

Nature(2021)10.1038/s41586-020-03144-0

N/A

0.826DataRank · unranked

246 citations

Gunjan Mandal, Kyle K. Payne, Carmen M. Anadon, Chandler Gatenbee, Ricardo A. Chaurio +18 more

The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.03.018

N/A

0.415DataRank · unranked

10 citations

William P. Tew, Christopher Purdy, S. Dennis, Andrew Menzin, John L. Lovecchio +16 more

Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.07.675

N/A

0.406DataRank · unranked

9 citations

Roisin E. O’Cearbhaill, Matthew S. Block, Erika Hamilton, Jason Konner, Keith L. Knutson +5 more

Carboplatin dosing in the treatment of ovarian cancer: An NRG oncology group study

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.013

N/A

0.104DataRank · unranked

1 citations

Austin Miller, Judith A. Smith, Stuart M. Lichtman, Michael A. Bookman, Carol Aghajanian +17 more

Determinants of response to checkpoint inhibition in ovarian cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17538

N/A

0DataRank · unranked

0 citations

Alexandra Martin, Jun Zhou, David Boulware, José R. Conejo-García, Robert M. Wenham +1 more

The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.028

N/A

0DataRank · unranked

14 citations

Chunqiao Tian, Joshua P. Kesterson, Michael Richardson, Ken Lin, Krishnansu S. Tewari +14 more